Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Update

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the target of a large decline in short interest in September. As of September 30th, there was short interest totalling 1,510,000 shares, a decline of 64.1% from the September 15th total of 4,210,000 shares. Currently, 3.1% of the company’s stock are short sold. Based on an […]

Related Keywords

Stephen Ray Mitchell ,Vanda Pharmaceuticals Company Profile ,Nasdaq ,Renaissance Technologies ,Vanda Pharmaceuticals ,Securities Exchange Commission ,Hedge Funds Weigh In On Vanda Pharmaceuticals ,News Ratings For Vanda Pharmaceuticals Daily ,Vanda Pharmaceuticals Stock Performance ,Dimensional Fund Advisors ,Vanguard Group Inc ,Blackrock Inc ,Vanda Pharmaceuticals Inc ,Get Free Report ,Director Stephen Ray Mitchell ,Exchange Commission ,Street Corp ,Fund Advisors ,Pharmaceuticals Inc ,Vanda Pharmaceuticals Daily ,Nasdaq Vnda ,Vnda ,Medical ,92165910 ,Stocks ,Options ,Put ,Call ,